Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.41 and traded as low as $0.22. Cell MedX shares last traded at $0.30, with a volume of 204,286 shares changing hands.
Cell MedX Price Performance
The firm’s 50-day moving average price is $0.40 and its two-hundred day moving average price is $0.26.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Articles
- Five stocks we like better than Cell MedX
- ESG Stocks, What Investors Should Know
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Health Care Stocks Explained: Why You Might Want to Invest
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
